ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
WuXi Biologics Congratulates Tychan on Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers
November 19, 2019WuXi Biologics congratulates its partner Tychan on successful completion of the Phase 1A/1B safety and efficacy trials in Singapore for TY014, a first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF). -
World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers
November 15, 2019Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF), called TY014, has successfully completed Phase 1A/1B safety trials in Singapore, it announced.
Pharma Sources Insight January 2025
